CG 8840
Alternative Names: CV 884Latest Information Update: 16 Oct 2006
At a glance
- Originator Cell Genesys
- Class Antineoplastics; Oncolytic viruses
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bladder cancer